MA24747A1 - Composition de mesylate de trovafloxacine et procede pour sa preparation - Google Patents

Composition de mesylate de trovafloxacine et procede pour sa preparation

Info

Publication number: MA24747A1
Authority: MA; Morocco
Prior art keywords: preparation; trovafloxacin mesylate; mesylate composition; composition; trovafloxacin
Prior art date: 1998-01-21

Application number

MA25433A

Other languages

English (en)

Inventor

Dale Johnson Alton

Michael Sinko Christopher

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-21

Filing date

1999-01-15

Publication date

1999-10-01

1999-01-15 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-10-01 Publication of MA24747A1 publication Critical patent/MA24747A1/fr

Links

229960005021 trovafloxacin mesylate Drugs 0.000 title 1
DYNZICQDCVYXFW-AHZSKCOESA-N trovafloxacin mesylate Chemical compound CS(O)(=O)=O.C([C@H]1[C@@H]([C@H]1C1)N)N1C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC=C(F)C=C1F DYNZICQDCVYXFW-AHZSKCOESA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MA25433A 1998-01-21 1999-01-15 Composition de mesylate de trovafloxacine et procede pour sa preparation MA24747A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7201398P	1998-01-21	1998-01-21

Publications (1)

Publication Number	Publication Date
MA24747A1 true MA24747A1 (fr)	1999-10-01

Family

ID=22105016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25433A MA24747A1 (fr)	1998-01-21	1999-01-15	Composition de mesylate de trovafloxacine et procede pour sa preparation

Country Status (34)

Country	Link
US (1)	US6187341B1 (fr)
EP (1)	EP0930068A3 (fr)
JP (1)	JPH11269072A (fr)
KR (1)	KR100314977B1 (fr)
CN (1)	CN1227743A (fr)
AP (1)	AP1094A (fr)
AR (1)	AR012780A1 (fr)
AU (1)	AU758381B2 (fr)
BG (1)	BG103106A (fr)
BR (1)	BR9900116A (fr)
CA (1)	CA2259698C (fr)
CO (1)	CO4810225A1 (fr)
DZ (1)	DZ2712A1 (fr)
EA (1)	EA003247B1 (fr)
GT (1)	GT199900004A (fr)
HR (1)	HRP990023A2 (fr)
HU (1)	HUP9900154A3 (fr)
ID (1)	ID23735A (fr)
IL (1)	IL128051A0 (fr)
IS (1)	IS4947A (fr)
MA (1)	MA24747A1 (fr)
NO (1)	NO990243L (fr)
NZ (1)	NZ333838A (fr)
OA (1)	OA10958A (fr)
PA (1)	PA8466701A1 (fr)
PE (1)	PE20000169A1 (fr)
PL (1)	PL330981A1 (fr)
SG (1)	SG70666A1 (fr)
SK (1)	SK4299A3 (fr)
TN (1)	TNSN99007A1 (fr)
TR (1)	TR199900089A3 (fr)
TW (1)	TW518224B (fr)
YU (1)	YU2399A (fr)
ZA (1)	ZA99393B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200101310T2 (tr) *	1998-11-10	2001-10-22	Bayer Aktiengesellschaft	Farmasötik moksifloksasin preparatı.
WO2001021211A2 (fr) *	1999-09-20	2001-03-29	Alza Corporation	Procede destine a reduire la transformation polymorphique d'un medicament
HU230030B1 (hu) *	1999-10-08	2015-05-28	Debiopharm International Sa	Fab I inhibitorok
FR2808441B1 (fr) *	2000-05-04	2004-06-18	Oreal	Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) *	2000-06-26	2002-02-14	Bayer Ag	Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
EP1560584B1 (fr) *	2001-04-06	2009-01-14	Affinium Pharmaceuticals, Inc.	Inhibiteurs de fab i
EP1396263A1 (fr) *	2002-08-09	2004-03-10	Warner-Lambert Company	Compositions d'enrobage pour tablettes et caplets
EP1575951B1 (fr) *	2002-12-06	2014-06-25	Debiopharm International SA	Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
CN100415284C (zh) *	2002-12-30	2008-09-03	毛友昌	六味木香片的制备方法
WO2004082586A2 (fr)	2003-03-17	2004-09-30	Affinium Pharmaceuticals, Inc.	Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
EP1459739B1 (fr) *	2003-03-19	2008-01-02	The Jordanian Pharmaceutical Manufacturing Co. Ltd.	Compositions pharmaceutiques non-hygroscopique contenant des acides carboxiliques quinilones non-hydratés
US8906413B2 (en)	2003-05-12	2014-12-09	Supernus Pharmaceuticals, Inc.	Drug formulations having reduced abuse potential
WO2005009395A2 (fr) *	2003-07-23	2005-02-03	L. Perrigo Company	Composition contenant des fibres cellulosiques
DK1828167T3 (da)	2004-06-04	2014-10-20	Debiopharm Int Sa	Acrylamidderivater som antibiotiske midler
ES2531735T3 (es) *	2004-10-15	2015-03-18	Supernus Pharmaceuticals, Inc.	Preparaciones farmacéuticas con menor potencial de abuso
KR20080075027A (ko) *	2005-12-05	2008-08-13	아피늄 파마슈티컬스, 인크.	Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
JP5468899B2 (ja)	2006-07-20	2014-04-09	アフィニウムファーマシューティカルズ，インク．	Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (fr)	2007-02-16	2014-08-20	Debiopharm Int Sa	Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
AU2013279021C1 (en)	2012-06-19	2017-03-16	Debiopharm International Sa	Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
RS61312B1 (sr)	2016-02-26	2021-02-26	Debiopharm Int Sa	Lek za lečenje infekcija dijabetskog stopala
TN2021000159A1 (en)	2019-02-14	2023-04-04	Debiopharm Int Sa	Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en)	2019-06-14	2021-12-30	Debiopharm Int Sa	Medicament and use thereof for treating bacterial infections involving biofilm
JP2025529185A (ja) *	2022-08-30	2025-09-04	パンネックスセラピューティクスインコーポレイテッド	パネキシン－１調節剤及びパネキシン－１が関与する疾患の治療方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3601566A1 (de) *	1986-01-21	1987-07-23	Bayer Ag	Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en)	1986-01-21	1994-02-15	Bayer Aktiengesellschaft	Pharmaceutical formulations of ciprofloxacin
US4957554A (en)	1989-08-16	1990-09-18	Minnesota Mining And Manufacturing Company	Dimensionally-controlled ceramics
DE4120646A1 (de)	1991-06-22	1992-12-24	Bayer Ag	7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
WO1997007800A1 (fr) *	1995-08-29	1997-03-06	Pfizer Inc.	Formes zwitterioniques de trovafloxacine

1999
- 1999-01-11 PA PA19998466701A patent/PA8466701A1/es unknown
- 1999-01-13 EP EP99300258A patent/EP0930068A3/fr not_active Withdrawn
- 1999-01-14 AP APAP/P/1999/001443A patent/AP1094A/en active
- 1999-01-14 TR TR1999/00089A patent/TR199900089A3/tr unknown
- 1999-01-14 SK SK42-99A patent/SK4299A3/sk unknown
- 1999-01-14 IL IL12805199A patent/IL128051A0/xx unknown
- 1999-01-15 OA OA9900009A patent/OA10958A/en unknown
- 1999-01-15 ID IDP990036D patent/ID23735A/id unknown
- 1999-01-15 MA MA25433A patent/MA24747A1/fr unknown
- 1999-01-15 PE PE1999000036A patent/PE20000169A1/es not_active Application Discontinuation
- 1999-01-15 GT GT199900004A patent/GT199900004A/es unknown
- 1999-01-19 AR ARP990100191A patent/AR012780A1/es not_active Application Discontinuation
- 1999-01-19 IS IS4947A patent/IS4947A/is unknown
- 1999-01-19 JP JP11010298A patent/JPH11269072A/ja active Pending
- 1999-01-19 CA CA002259698A patent/CA2259698C/fr not_active Expired - Fee Related
- 1999-01-19 BR BR9900116-0A patent/BR9900116A/pt not_active IP Right Cessation
- 1999-01-20 NO NO990243A patent/NO990243L/no not_active Application Discontinuation
- 1999-01-20 KR KR1019990001589A patent/KR100314977B1/ko not_active Expired - Fee Related
- 1999-01-20 US US09/233,823 patent/US6187341B1/en not_active Expired - Fee Related
- 1999-01-20 SG SG1999000117A patent/SG70666A1/en unknown
- 1999-01-20 AU AU12173/99A patent/AU758381B2/en not_active Ceased
- 1999-01-20 YU YU2399A patent/YU2399A/sh unknown
- 1999-01-20 NZ NZ333838A patent/NZ333838A/xx unknown
- 1999-01-20 HU HU9900154A patent/HUP9900154A3/hu unknown
- 1999-01-20 TN TNTNSN99007A patent/TNSN99007A1/fr unknown
- 1999-01-20 DZ DZ990013A patent/DZ2712A1/fr active
- 1999-01-20 PL PL99330981A patent/PL330981A1/xx unknown
- 1999-01-20 CN CN99101232A patent/CN1227743A/zh active Pending
- 1999-01-20 ZA ZA9900393A patent/ZA99393B/xx unknown
- 1999-01-21 BG BG103106A patent/BG103106A/xx unknown
- 1999-01-21 CO CO99003190A patent/CO4810225A1/es unknown
- 1999-01-21 EA EA199900046A patent/EA003247B1/ru not_active IP Right Cessation
- 1999-01-21 TW TW088100897A patent/TW518224B/zh not_active IP Right Cessation
- 1999-01-21 HR HR60/072,013A patent/HRP990023A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU1217399A (en)	1999-08-12
OA10958A (en)	2001-10-31
AR012780A1 (es)	2000-11-08
US6187341B1 (en)	2001-02-13
TR199900089A2 (xx)	1999-10-21
KR100314977B1 (ko)	2001-11-24
PL330981A1 (en)	1999-08-02
HUP9900154A2 (hu)	1999-09-28
NZ333838A (en)	2000-03-27
EP0930068A2 (fr)	1999-07-21
EA199900046A2 (ru)	1999-08-26
AP9901443A0 (en)	1999-03-31
NO990243D0 (no)	1999-01-20
IL128051A0 (en)	1999-11-30
BG103106A (en)	1999-08-31
HUP9900154A3 (en)	2000-12-28
IS4947A (is)	1999-07-22
PA8466701A1 (es)	2000-09-29
BR9900116A (pt)	2000-05-02
ZA99393B (en)	2000-07-21
KR19990068014A (ko)	1999-08-25
NO990243L (no)	1999-07-22
YU2399A (sh)	2002-06-19
SK4299A3 (en)	2000-06-12
TW518224B (en)	2003-01-21
JPH11269072A (ja)	1999-10-05
SG70666A1 (en)	2000-02-22
CO4810225A1 (es)	1999-06-30
CN1227743A (zh)	1999-09-08
CA2259698C (fr)	2003-04-15
GT199900004A (es)	2000-07-08
ID23735A (id)	2000-05-11
EP0930068A3 (fr)	1999-12-22
TNSN99007A1 (fr)	2005-11-10
AU758381B2 (en)	2003-03-20
EA003247B1 (ru)	2003-02-27
PE20000169A1 (es)	2000-03-10
EA199900046A3 (ru)	1999-12-29
TR199900089A3 (tr)	1999-10-21
HRP990023A2 (en)	1999-08-31
DZ2712A1 (fr)	2003-09-01
AP1094A (en)	2002-08-19
CA2259698A1 (fr)	1999-07-21
HU9900154D0 (en)	1999-03-29

Publication	Publication Date	Title
MA24747A1 (fr)	1999-10-01	Composition de mesylate de trovafloxacine et procede pour sa preparation
FR2795734B1 (fr)	2005-09-30	Conjugues d'erythropoietine,compositons les comprenant et procede pour leur preparation
MA25089A1 (fr)	2000-12-31	Formulations intranasales de mesylate de sildenafil et procede pour leur preparation
FR2791580B1 (fr)	2001-05-04	Procede pour l'enrobage de particules
FR2773807B1 (fr)	2000-02-25	Materiau cellulaire souple, composition et procede pour sa preparation
EP1156324A4 (fr)	2007-03-21	Procede de differentiation d'echantillons
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
HUP0104582A3 (en)	2002-12-28	1,2-annelated quinoline derivatives, pharmaceutical compositions thereof, intermediates and process for their preparation
FR2752091B1 (fr)	1998-09-04	Composition pour electrode positive, procede de preparation
MA25223A1 (fr)	2001-07-02	Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
MA25984A1 (fr)	2003-12-31	Procede pour preparation de maleate d'amlodipine.
FR2780728B1 (fr)	2001-02-16	Sel de paroxetine nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
EE04739B1 (et)	2006-12-15	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ning vaheühend ja selle valmistamismeetod
EE03679B1 (et)	2002-04-15	Bensüüleetrite valmistamise protsess
EE200100574A (et)	2003-02-17	Uued ühendid, nende valmistamise meetod ning kasutamine
MA24182A1 (fr)	1997-12-31	Procede pour la preparation de 2,4-diaminopyrimidines substituees
EP0938901A4 (fr)	2001-10-31	Compositions medicinales pour traiter les affections hepatiques
FR2781801B1 (fr)	2004-10-15	Procede pour la preparation de dianhydride pyromellique
EE200000651A (et)	2002-04-15	Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
FR2818979B1 (fr)	2003-05-30	Procede de preparation d'imidaclopride
FR2773558B1 (fr)	2000-02-18	Procede pour l'obtention de 1-butene
EE200100573A (et)	2003-02-17	Uued ühendid, nende valmistamise meetod ning kasutamine
NO20004968L (no)	2000-12-01	Mastikblanding og fremgangsmåte til fremstilling derav
EP1071746A4 (fr)	2003-04-23	Procede de preparation de doxorubicine
MA26710A1 (fr)	2004-12-20	Formulations de doramectine antiparasitaires et procede pour leur preparation